amiodarone has been researched along with Diffuse Parenchymal Lung Disease in 64 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of the study was to assess the diagnostic accuracy of pCLE for amiodarone-related pneumonia (AMR-IP)." | 9.17 | In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia. ( Bergot, E; Bourg-Heckly, G; Dominique, S; Genevois, A; Jounieaux, V; Roussel, F; Salaün, M; Thiberville, L; Vergnon, JM; Vever-Bizet, C; Zalcman, G, 2013) |
| "Although oral amiodarone (AMD) has been used for the management of atrial fibrillation (AF), serious complications such as interstitial pneumonia (IP) occur very occasionally." | 7.83 | Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients. ( Fujino, T; Fukunaga, S; Ikeda, T; Kinoshita, T; Kitahara, K; Kobayashi, K; Koike, H; Koike, M; Sato, H; Shinohara, M; Suzuki, T; Yuzawa, H, 2016) |
| "Amiodarone use has been rarely associated with the development of acute respiratory distress syndrome (ARDS), usually in association with surgery or pulmonary angiography." | 7.78 | Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. ( Bangalore, S; Grosu, H; Jean, R; Kumar, S; Kumari, R, 2012) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 7.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "Amiodarone is a widely used antiarrhythmic agent for supraventricular and ventricular tachyarrhythmias." | 5.46 | Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids. ( Chatterjee, K; Khasawneh, K; Kuriakose, K; Paydak, H; Rochlani, YM, 2017) |
| "Amiodarone is a highly effective antiarrhythmic agent used in life-threatening ventricular and supraventricular arrhythmias." | 5.35 | Amiodarone induced pneumonitis and hyperthyroidism: case report. ( Ambroziak, U; Bareła, AD; Chazan, R; Grabczak, EM; Opuchlik, A; Potulska, A; Wiwała, J; Zielonka, TM, 2008) |
| " The objective of the study was to assess the diagnostic accuracy of pCLE for amiodarone-related pneumonia (AMR-IP)." | 5.17 | In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia. ( Bergot, E; Bourg-Heckly, G; Dominique, S; Genevois, A; Jounieaux, V; Roussel, F; Salaün, M; Thiberville, L; Vergnon, JM; Vever-Bizet, C; Zalcman, G, 2013) |
| "Although oral amiodarone (AMD) has been used for the management of atrial fibrillation (AF), serious complications such as interstitial pneumonia (IP) occur very occasionally." | 3.83 | Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients. ( Fujino, T; Fukunaga, S; Ikeda, T; Kinoshita, T; Kitahara, K; Kobayashi, K; Koike, H; Koike, M; Sato, H; Shinohara, M; Suzuki, T; Yuzawa, H, 2016) |
| "Amiodarone use has been rarely associated with the development of acute respiratory distress syndrome (ARDS), usually in association with surgery or pulmonary angiography." | 3.78 | Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. ( Bangalore, S; Grosu, H; Jean, R; Kumar, S; Kumari, R, 2012) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 3.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "We report amiodarone-induced pulmonary toxicity in an 18-year-old boy who had undergone corrective surgery for tetralogy of Fallot 4 years earlier, and was treated with amiodarone because of recurrent malignant postoperative ventricular tachyarrhythmias." | 3.70 | Amiodarone-induced pulmonary toxicity in an adolescent. ( Balijepally, S; Kothari, SS; Taneja, K, 1999) |
| " Cells were obtained from patients with idiopathic pulmonary fibrosis (n = 10), patients with sarcoidosis (n = 20), and patients receiving amiodarone without evidence of clinical lung disease (n = 10) as well as from normal volunteers (n = 8)." | 3.68 | Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles. ( Auerbach, R; Meyer, KC; Powers, C; Rosenthal, N, 1993) |
| "Drug-induced interstitial lung disease has been reported as a severe adverse effect of some drugs, such as bleomycin, amiodarone, and methotrexate." | 2.82 | Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics. ( Li, S; Shi, J; Tang, H, 2022) |
| "Four patients with interstitial lung disease who were treated by amiodarone for ischemic heart diseases were evaluated by a conventional clinical workup." | 2.73 | The role of induced sputum in amiodarone-associated interstitial lung diseases. ( Fireman, E; Priel, IE; Topilsky, I; Viskin, S, 2007) |
| "Amiodarone is a drug commonly used to treat and prevent cardiac arrhythmias, but it is often associated with several adverse effects, the most serious of which is pulmonary toxicity." | 2.72 | A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia. ( Aspromonte, N; Cappannoli, L; Crea, F; Massetti, M; Petrolati, E; Rabini, A; Scacciavillani, R; Smargiassi, A; Telesca, A, 2021) |
| "Diagnosis of extrinsic allergic alveolitis is based on the association of clinical, radiological, functional, immunological criteria and bronchoalveolar lavage fluid analysis." | 2.41 | [Diffuse infiltrative lung diseases due to allergy and iatrogenic causes]. ( Dalphin, JC, 2000) |
| " The most serious adverse reaction is pulmonary toxicity." | 2.40 | [Amiodarone-induced pulmonary toxicity]. ( Berg, M; Heisel, A; Schieffer, H; Stopp, M; Ukena, D, 1997) |
| "Amiodarone is an antiarrhythmic agent that is used commonly in clinical practice." | 1.51 | Amiodarone-induced diffuse alveolar haemorrhage: a rare but potentially life-threatening complication of a commonly prescribed medication. ( Abdullah, HMA; Khan, UI; Saeed, J; Waqas, QA, 2019) |
| "Amiodarone is a widely used antiarrhythmic agent for supraventricular and ventricular tachyarrhythmias." | 1.46 | Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids. ( Chatterjee, K; Khasawneh, K; Kuriakose, K; Paydak, H; Rochlani, YM, 2017) |
| "Amiodarone is a highly effective antiarrhythmic agent." | 1.42 | ECMO for pulmonary rescue in an adult with amiodarone-induced toxicity. ( Benassi, F; Meli, M; Molardi, A; Righi, E; Santangelo, R, 2015) |
| "Dronedarone is an amiodarone-like antiarrhythmic with a modified structure." | 1.42 | Diffuse alveolar damage in a patient receiving dronedarone. ( Ahuja, N; Casto, A; Nguyen, DV; Stack, S, 2015) |
| "Idiopathic pulmonary fibrosis (IPF), the most common and lethal of the idiopathic interstitial pneumonias, is defined by a radiological and/or pathological pattern of usual interstitial pneumonia (UIP)." | 1.40 | Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic? ( Bonella, F; Cavazza, A; Rossi, G; Spagnolo, P; Sverzellati, N; Wuyts, WA, 2014) |
| " Due to a very long half-life, accumulation can only be prevented by strict adherence to certain dosage patterns." | 1.39 | Amiodarone-induced pulmonary toxicity--a fatal case report and literature review. ( Breithardt, G; Buerke, B; Hilker, E; Lebiedz, P; Range, FT, 2013) |
| "Amiodarone is a highly effective antiarrhythmic agent used in life-threatening ventricular and supraventricular arrhythmias." | 1.35 | Amiodarone induced pneumonitis and hyperthyroidism: case report. ( Ambroziak, U; Bareła, AD; Chazan, R; Grabczak, EM; Opuchlik, A; Potulska, A; Wiwała, J; Zielonka, TM, 2008) |
| "Phase I of this study involved compilation of a database of adverse reactions to amiodarone reported to the Australian and US drug agencies, and identification of risk factors for AIPT using logistic regression analysis." | 1.35 | Amiodarone-induced pulmonary toxicity. ( Ernawati, DK; Hughes, JD; Stafford, L, 2008) |
| "We present a patient with COPD, in whom interstitial pneumonitis with radiologic features of organizing pneumonia developed after one year of amiodaron treatment due to supraventricular and ventricular arrhythmias." | 1.35 | [Interstitial pneumonitis in a patient treated with amiodarone -- case report]. ( Burakowska, B; Fijałkowska, A; Paczek, A; Szturmowicz, M; Torbicki, A; Wiatr, E, 2008) |
| "The diagnosis was interstitial pneumonitis induced by amiodarone." | 1.33 | [Interstitial pneumonitis followed by syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy for dilated cardiomyopathy: a case report]. ( Arakawa, T; Hashimoto, Y; Ichihara, N; Isobe, M; Matsumura, A; Sato, S; Suzuki, M; Yoshikawa, S, 2006) |
| "Amiodarone-induced lung injury has characteristic pathologic features which may provide clues to diagnosis." | 1.33 | [Clinicopathologic manifestation of amiodarone-induced lung injury]. ( Liu, HR; Shi, JH; Xu, WB; Zhu, YJ, 2006) |
| "Amiodarone treatment was terminated, and the patient was given corticosteroids." | 1.33 | Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse. ( Kobayashi, N; Kojima, J; Kudo, K; Okayasu, K; Sugiyama, H; Takeda, Y; Yoshizawa, A, 2006) |
| "AIPT-I had interstitial pneumonitis (n=4) and AIPT-II had interstitial pneumonitis with fibrosis (n=5)." | 1.32 | Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity. ( Altaner, S; Altun, A; Berkada, S; Durmus-Altun, G; Ozbay, G; Sami Salihoglu, Y, 2004) |
| "Amiodarone is a useful drug for the treatment of life-threatening cardiac arrhythmias." | 1.31 | Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity. ( Kawahara, Y; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y; Yoshida, K, 2000) |
| "Amiodarone is an antiarrhythmic drug that can cause interstitial pneumonitis leading to pulmonary fibrosis." | 1.31 | HRCT findings of amiodarone pulmonary toxicity: clinical and radiologic regression. ( Heering, P; Hetzel, G; Koch, JA; May, P; Mödder, U; Poll, LW, 2001) |
| "Amiodarone is an effective class-III antiarrhythmic agent." | 1.30 | [Spontaneous remission of an amiodarone-induced pulmonary lesion]. ( Müller, M; Schima, W; Weissel, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (20.31) | 18.2507 |
| 2000's | 29 (45.31) | 29.6817 |
| 2010's | 19 (29.69) | 24.3611 |
| 2020's | 3 (4.69) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S | 1 |
| Shi, J | 1 |
| Tang, H | 1 |
| Saeed, J | 1 |
| Waqas, QA | 1 |
| Khan, UI | 1 |
| Abdullah, HMA | 1 |
| Kinoshita, S | 1 |
| Hosomi, K | 1 |
| Yokoyama, S | 1 |
| Takada, M | 1 |
| Cappannoli, L | 1 |
| Telesca, A | 1 |
| Scacciavillani, R | 1 |
| Petrolati, E | 1 |
| Smargiassi, A | 1 |
| Rabini, A | 1 |
| Massetti, M | 1 |
| Crea, F | 1 |
| Aspromonte, N | 1 |
| Voruganti, DC | 1 |
| Cadaret, L | 1 |
| Kaya, SB | 1 |
| Deger, S | 1 |
| Hacievliyagil, SS | 1 |
| Aytemur, ZA | 1 |
| Roden, AC | 1 |
| Camus, P | 1 |
| Chatterjee, K | 1 |
| Rochlani, YM | 1 |
| Kuriakose, K | 1 |
| Khasawneh, K | 1 |
| Paydak, H | 1 |
| Kubo, K | 1 |
| Azuma, A | 1 |
| Kanazawa, M | 1 |
| Kameda, H | 1 |
| Kusumoto, M | 1 |
| Genma, A | 1 |
| Saijo, Y | 1 |
| Sakai, F | 1 |
| Sugiyama, Y | 1 |
| Tatsumi, K | 1 |
| Dohi, M | 1 |
| Tokuda, H | 1 |
| Hashimoto, S | 1 |
| Hattori, N | 1 |
| Hanaoka, M | 1 |
| Fukuda, Y | 1 |
| Benassi, F | 1 |
| Molardi, A | 1 |
| Righi, E | 1 |
| Santangelo, R | 1 |
| Meli, M | 1 |
| Wuyts, WA | 1 |
| Cavazza, A | 1 |
| Rossi, G | 1 |
| Bonella, F | 1 |
| Sverzellati, N | 1 |
| Spagnolo, P | 1 |
| Stack, S | 1 |
| Nguyen, DV | 1 |
| Casto, A | 1 |
| Ahuja, N | 1 |
| Scheschkowski, T | 1 |
| Budweiser, S | 1 |
| Koike, H | 1 |
| Fujino, T | 1 |
| Koike, M | 1 |
| Shinohara, M | 1 |
| Kitahara, K | 1 |
| Kinoshita, T | 1 |
| Yuzawa, H | 1 |
| Suzuki, T | 1 |
| Sato, H | 1 |
| Fukunaga, S | 1 |
| Kobayashi, K | 1 |
| Ikeda, T | 1 |
| Hori, Y | 1 |
| Nakahara, S | 1 |
| Mine, S | 1 |
| Anjo, N | 1 |
| Fujii, A | 1 |
| Ueda, Y | 1 |
| Taguchi, I | 1 |
| Grabczak, EM | 1 |
| Zielonka, TM | 1 |
| Wiwała, J | 1 |
| Bareła, AD | 1 |
| Opuchlik, A | 1 |
| Potulska, A | 1 |
| Ambroziak, U | 1 |
| Chazan, R | 1 |
| Lehmann, LH | 1 |
| Weichert, W | 1 |
| Schnapauff, D | 1 |
| Dietz, R | 1 |
| Stockburger, M | 1 |
| Heisel, A | 1 |
| Berg, M | 1 |
| Stopp, M | 1 |
| Ukena, D | 1 |
| Schieffer, H | 1 |
| Shimada, YJ | 1 |
| Sato, K | 1 |
| Hanon, S | 1 |
| Schweitzer, P | 1 |
| Freise, J | 1 |
| Wehmeier, P | 1 |
| Welte, T | 1 |
| Tanawuttiwat, T | 1 |
| Harindhanavudhi, T | 1 |
| Hanif, S | 1 |
| Sahloul, MZ | 1 |
| Kumar, S | 1 |
| Bangalore, S | 1 |
| Kumari, R | 1 |
| Grosu, H | 1 |
| Jean, R | 1 |
| Jackevicius, CA | 1 |
| Tom, A | 1 |
| Essebag, V | 1 |
| Eisenberg, MJ | 1 |
| Rahme, E | 1 |
| Tu, JV | 1 |
| Humphries, K | 1 |
| Behlouli, H | 1 |
| Pilote, L | 1 |
| Hernández Voth, AR | 1 |
| Catalán, JS | 1 |
| Benavides Mañas, PD | 1 |
| Avila Martínez, RJ | 1 |
| Peñalver Paolini, CL | 1 |
| Díaz de Atauri Rodríguez, MJ | 1 |
| Salaün, M | 1 |
| Roussel, F | 1 |
| Bourg-Heckly, G | 1 |
| Vever-Bizet, C | 1 |
| Dominique, S | 1 |
| Genevois, A | 1 |
| Jounieaux, V | 1 |
| Zalcman, G | 1 |
| Bergot, E | 1 |
| Vergnon, JM | 1 |
| Thiberville, L | 1 |
| Range, FT | 1 |
| Hilker, E | 1 |
| Breithardt, G | 1 |
| Buerke, B | 1 |
| Lebiedz, P | 1 |
| Umetani, K | 1 |
| Abe, M | 1 |
| Kawabata, K | 1 |
| Iida, T | 1 |
| Kohno, I | 1 |
| Sawanobori, T | 1 |
| Kugiyama, K | 1 |
| Malhotra, A | 1 |
| Muse, VV | 1 |
| Mark, EJ | 1 |
| Durmus-Altun, G | 1 |
| Altun, A | 1 |
| Sami Salihoglu, Y | 1 |
| Altaner, S | 1 |
| Berkada, S | 1 |
| Ozbay, G | 1 |
| Omeroglu, G | 1 |
| Kalugina, Y | 1 |
| Ersahin, C | 1 |
| Wojcik, EM | 1 |
| Itoh, Y | 1 |
| Sendo, T | 1 |
| Oishi, R | 1 |
| Yoshikawa, S | 1 |
| Suzuki, M | 1 |
| Ichihara, N | 1 |
| Sato, S | 1 |
| Arakawa, T | 1 |
| Matsumura, A | 1 |
| Hashimoto, Y | 1 |
| Isobe, M | 1 |
| Shi, JH | 1 |
| Liu, HR | 1 |
| Zhu, YJ | 1 |
| Xu, WB | 1 |
| Fireman, E | 1 |
| Topilsky, I | 1 |
| Viskin, S | 1 |
| Priel, IE | 1 |
| Okayasu, K | 1 |
| Takeda, Y | 1 |
| Kojima, J | 1 |
| Yoshizawa, A | 1 |
| Kobayashi, N | 1 |
| Sugiyama, H | 1 |
| Kudo, K | 1 |
| Kimura, M | 1 |
| Ogawa, H | 1 |
| Wakeyama, T | 1 |
| Takaki, A | 1 |
| Iwami, T | 1 |
| Hadano, Y | 1 |
| Miyazaki, Y | 1 |
| Shimizu, A | 1 |
| Matsuzaki, M | 1 |
| Rayner, B | 1 |
| Golomb, BA | 1 |
| Evans, MA | 1 |
| Tsukada, YT | 1 |
| Kishida, H | 1 |
| Emby, DJ | 1 |
| Ernawati, DK | 1 |
| Stafford, L | 1 |
| Hughes, JD | 1 |
| Paczek, A | 1 |
| Szturmowicz, M | 1 |
| Wiatr, E | 1 |
| Burakowska, B | 1 |
| Fijałkowska, A | 1 |
| Torbicki, A | 1 |
| Pitton, MB | 1 |
| Schweden, F | 1 |
| Lenci, G | 1 |
| Ansoborlo, P | 1 |
| Constans, J | 1 |
| Le Métayer, P | 1 |
| Conri, C | 1 |
| Mathru, M | 1 |
| McDaniel, LB | 1 |
| Meyer, KC | 1 |
| Powers, C | 1 |
| Rosenthal, N | 1 |
| Auerbach, R | 1 |
| Vizioli, LD | 1 |
| Cho, S | 1 |
| Carvalho, CR | 1 |
| Kairalla, RA | 1 |
| Capelozzi, VL | 1 |
| Amato, MB | 1 |
| Saldiva, PH | 1 |
| Villain, E | 1 |
| Müller, M | 1 |
| Schima, W | 1 |
| Weissel, M | 1 |
| de Granda Orive, JI | 1 |
| Herrera de la Rosa, A | 1 |
| Martínez Albiach, JM | 1 |
| Escobar Sacristán, JA | 1 |
| Sáez Valls, R | 1 |
| Gallego Rodríguez, V | 1 |
| Kothari, SS | 1 |
| Balijepally, S | 1 |
| Taneja, K | 1 |
| Cockcroft, DW | 1 |
| Fisher, KL | 1 |
| Wilhelm, JM | 1 |
| Thannberger, P | 1 |
| Derragui, A | 1 |
| Ruxer, S | 1 |
| Saraceni, O | 1 |
| Kieffer, P | 1 |
| Endoh, Y | 2 |
| Hanai, R | 2 |
| Uto, K | 2 |
| Uno, M | 1 |
| Nagashima, H | 1 |
| Narimatsu, A | 1 |
| Takizawa, T | 1 |
| Onishi, S | 1 |
| Kasanuki, H | 2 |
| Tanaka, T | 1 |
| Ohta, Y | 1 |
| Ohnishi, S | 1 |
| Dalphin, JC | 1 |
| Kohno, N | 1 |
| Yokoyama, A | 1 |
| Kondo, K | 1 |
| Nakajima, M | 1 |
| Kawahara, Y | 1 |
| Yoshida, K | 1 |
| Miyashita, N | 1 |
| Niki, Y | 1 |
| Matsushima, T | 1 |
| Stiefelhagen, P | 1 |
| Bhagat, R | 1 |
| Sporn, TA | 1 |
| Long, GD | 1 |
| Folz, RJ | 1 |
| Poll, LW | 1 |
| May, P | 1 |
| Koch, JA | 1 |
| Hetzel, G | 1 |
| Heering, P | 1 |
| Mödder, U | 1 |
| Trzpuc, TD | 1 |
| Shidham, VB | 1 |
| Rao, RN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endoscopic Follow-up of Low Grade Precancerous Bronchial Lesions in High Risk Patients (SELEPREBB1)[NCT00213603] | 365 participants (Actual) | Observational | 2002-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for amiodarone and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics.
Topics: Amiodarone; Animals; Bleomycin; Disease Models, Animal; Idiopathic Pulmonary Fibrosis; Lung; Lung Di | 2022 |
A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; COVID-19; Diagnosis, Differential; Humans; Lung Diseases, | 2021 |
Iatrogenic pulmonary lesions.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Drug-Related Side Effects and Adverse Rea | 2018 |
[Amiodarone-induced pulmonary toxicity].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bronchial Spasm; Controlled Clinical Trials as Topic; Cryptogeni | 1997 |
[Drug-induced lung diseases].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Ant | 2006 |
[Adverse effects of cardiovascular agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Brugada Syndrome; Drug Interactions; Fibrinolyti | 2007 |
[Diffuse infiltrative lung diseases due to allergy and iatrogenic causes].
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Anti-Arrhythmia Agents; Bronchoalveolar Lavage Fluid; Cr | 2000 |
3 trials available for amiodarone and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia.
Topics: Aged; Aged, 80 and over; Amiodarone; Bronchoalveolar Lavage; Bronchoscopy; Female; Fluorescent Dyes; | 2013 |
The role of induced sputum in amiodarone-associated interstitial lung diseases.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Diseases, Interstitial; Male; Myocard | 2007 |
Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Topics: Adult; Aged; Amiodarone; Antigens; Antigens, Neoplasm; Atrial Fibrillation; Biomarkers; C-Reactive P | 2000 |
54 other studies available for amiodarone and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Amiodarone-induced diffuse alveolar haemorrhage: a rare but potentially life-threatening complication of a commonly prescribed medication.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Hemorrhage; Humans; Lung | 2019 |
Inverse Association between Metformin and Amiodarone-Associated Extracardiac Adverse Events.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Humans; Hyperthyroidism; Hypoglycemic Agents; L | 2020 |
Amiodarone-induced interstitial pneumonitis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Dyspnea; Humans; Lung Diseases, Inters | 2017 |
Acute amiodarone toxicity causing respiratory failure.
Topics: Aged; Amiodarone; Humans; Lung; Lung Diseases, Interstitial; Male; Pneumonia; Radiography, Thoracic; | 2017 |
Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids.
Topics: Amiodarone; Anti-Arrhythmia Agents; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Midd | 2017 |
Consensus statement for the diagnosis and treatment of drug-induced lung injuries.
Topics: Acute Lung Injury; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents; Antineoplastic Agents; | 2013 |
ECMO for pulmonary rescue in an adult with amiodarone-induced toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Extracorporeal Membrane Oxygenation; Humans; Lung; | 2015 |
Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Arthritis, Rheumatoid; Diagnosis, Differential; Humans; | 2014 |
Diffuse alveolar damage in a patient receiving dronedarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biopsy; Diagnosis, Differential; Dron | 2015 |
[In Process Citation].
Topics: Aged; Amiodarone; Bronchoscopy; Dyspnea; Humans; Lung Diseases, Interstitial; Macrophages, Alveolar; | 2016 |
Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillati | 2016 |
Pathological autopsy of a patient that underwent a successful ablation of an electrical storm from the left ventricular summit.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Autopsy; Catheter Ablation; Electrocardiography; Electroph | 2016 |
Drug-induced interstitial pneumonia.
Topics: Amiodarone; Cytotoxins; Drug-Related Side Effects and Adverse Reactions; Humans; Imidazolidines; Lun | 2008 |
Amiodarone induced pneumonitis and hyperthyroidism: case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Humans; Hyperthyro | 2008 |
Interstitial pneumonitis with accumulation of intraalveolar macrophages, a facet amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases, Interstitial; Macrophages, Alveolar | 2008 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, H | 2009 |
[Drug-induced pulmonary interstitial disease].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Biopsy; Bronchoscopy; Como | 2010 |
Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Fatal Outcome; Hemorrhage; Humans; Lung Di | 2010 |
Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure.
Topics: Acute Disease; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Femal | 2012 |
Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Femal | 2011 |
A 73-year-old man with interstitial lung disease due to dronedarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Lung; Lung Disea | 2012 |
Amiodarone-induced pulmonary toxicity--a fatal case report and literature review.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Drug Overdose; Fatal Outcome; Hal | 2013 |
SP-D as a marker of amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Glucocorticoids; Glyco | 2002 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2003. An 82-year-old man with dyspnea and pulmonary abnormalities.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Bundle | 2003 |
Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity.
Topics: Aerosols; Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Diagnosis, Differential | 2004 |
Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Biopsy, Fine-Needle; Chronic Disease; Cryptogenic Organizi | 2006 |
[Interstitial pneumonitis followed by syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy for dilated cardiomyopathy: a case report].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Humans; Inappropriat | 2006 |
[Clinicopathologic manifestation of amiodarone-induced lung injury].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Follow-Up Studies; Glucocorticoids; Humans; Lung; | 2006 |
Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Body Mass Index; Cardiomyopathy | 2006 |
[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiomy | 2006 |
Clinical lessons from an elderly man with amiodarone-induced interstitial lung disease.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Asbestosis; Diagnostic Errors; Humans; Lung D | 2007 |
Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.
Topics: Amiodarone; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductas | 2007 |
Amiodarone-induced lung disease.
Topics: Amiodarone; Diagnosis, Differential; Humans; Lung Diseases, Interstitial; Radiography, Thoracic; Tom | 2008 |
Amiodarone-induced pulmonary toxicity.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Diseases, Intersti | 2008 |
[Interstitial pneumonitis in a patient treated with amiodarone -- case report].
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases, Interstiti | 2008 |
[Computerized tomography aspects of amiodarone poisoning].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Female | 1995 |
[Pneumopathy caused by amiodarone in internal medicine: 8 cases].
Topics: Aged; Aged, 80 and over; Amiodarone; Dyspnea; Female; Humans; Lung Diseases, Interstitial; Male; Ret | 1993 |
Primum non nocere. Is the therapy worse than the disease?
Topics: Amiodarone; Humans; Lung; Lung Diseases, Interstitial; Pneumonectomy; Postoperative Complications; P | 1994 |
Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Binding, Competitive; Bronchoalveolar Lavage | 1993 |
Amiodarone-associated hemoptysis.
Topics: Aged; Aged, 80 and over; Amiodarone; Hemoptysis; Humans; Lung; Lung Diseases, Interstitial; Male | 1994 |
Chronic amiodarone ingestion induces pulmonary toxicity in rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Lung; Lung Diseases, Interstitial; Male; Microscopy, El | 1996 |
Amiodarone as treatment for atrial tachycardias after surgery.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Cathete | 1997 |
[Spontaneous remission of an amiodarone-induced pulmonary lesion].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Lung Diseases, Interstitial; Radiog | 1997 |
[Amiodarone pulmonary toxicity: radiological coexistence of nodules with interstitial and alveolar abnormalities].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Diseases, Interstitial; Radiography | 1998 |
Amiodarone-induced pulmonary toxicity in an adolescent.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Drug Therapy, Combinati | 1999 |
Near normalization of spirometry in a subject with severe emphysema complicated by amiodarone lung.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Emphysema; Forced Expiratory Volume; Humans; Lung Diseases | 1999 |
[Interstitial pneumopathy 2 months after discontinuing treatment with amiodarone].
Topics: Aged; Amiodarone; Humans; Long-Term Care; Lung Diseases, Interstitial; Male; Myocardial Ischemia; Su | 1999 |
KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; C-Reactive Prote | 2000 |
KL-6 as a serum marker for amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Diagnosis, Differentia | 2000 |
Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Carbon Monoxide; Cardi | 2000 |
[Diagnostic quiz. Increasing dyspnea after bypass operation. Interstitial lung disease].
Topics: Aged; Amiodarone; Coronary Artery Bypass; Humans; Lung Diseases, Interstitial; Male; Myocardial Infa | 2001 |
Amiodarone and cyclophosphamide: potential for enhanced lung toxicity.
Topics: Amiodarone; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Synergism; Drug-R | 2001 |
HRCT findings of amiodarone pulmonary toxicity: clinical and radiologic regression.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Respirat | 2001 |
Pathologic quiz case: pulmonary infiltrates with characteristic light and electron microscopic features.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Collagen Diseases; Diagnosis, Differentia | 2002 |